The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Monoclonal Antibodies-Global Market Insights and Sales Trends 2024
Synopsis
Monoclonal antibody therapeutics is a type of immunotherapy in which monoclonal antibodies are used so that they can bind monospecifically to specific cells and proteins.
The global Monoclonal Antibodies market size is expected to reach US$ 144360 million by 2029, growing at a CAGR of 4.5% from 2023 to 2029. The market is mainly driven by the significant applications of Monoclonal Antibodies in various end use industries. The expanding demands from the Anti-Cancer and Anti-Inflammatory/Autoimmune, are propelling Monoclonal Antibodies market. Erythropoietin (EPO), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Human Growth Hormone (HGH) segment is estimated at % CAGR for the next seven-year period.
This treatment stimulates the immune system of patients to attack the foreign cells which cause the disease. Monoclonal antibodies are produced by using hybridoma technology. In hybridoma technology, the antibodies are obtained by fusion of human spleen cells and human myeloma. The characteristics of monoclonal antibodies which affect their efficacy are antigen specificity, overall structure and the affinity of the antibody for the target antigen or cells.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Monoclonal Antibodies, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Monoclonal Antibodies market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Monoclonal Antibodies market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Monoclonal Antibodies sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Monoclonal Antibodies covered in this report include Biocon, Celltrion, Dr. Reddy's Laboratories, Hospira, 3SBio, Accord Healthcare, AET Biotech, Allergan and Amega Biotech, etc.
The global Monoclonal Antibodies market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Biocon
Celltrion
Dr. Reddy's Laboratories
Hospira
3SBio
Accord Healthcare
AET Biotech
Allergan
Amega Biotech
Global Monoclonal Antibodies market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Monoclonal Antibodies market, Segment by Type:
Erythropoietin (EPO)
Human Growth Hormone (HGH)
Granulocyte- Colony Stimulating Factor (G-CSF)
Monoclonal Antibody (mAb)
Insulin
Interferon (IFN)
Others
Global Monoclonal Antibodies market, by Application
Anti-Cancer
Anti-Inflammatory/Autoimmune
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Monoclonal Antibodies manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Monoclonal Antibodies in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Monoclonal antibody therapeutics is a type of immunotherapy in which monoclonal antibodies are used so that they can bind monospecifically to specific cells and proteins.
The global Monoclonal Antibodies market size is expected to reach US$ 144360 million by 2029, growing at a CAGR of 4.5% from 2023 to 2029. The market is mainly driven by the significant applications of Monoclonal Antibodies in various end use industries. The expanding demands from the Anti-Cancer and Anti-Inflammatory/Autoimmune, are propelling Monoclonal Antibodies market. Erythropoietin (EPO), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Human Growth Hormone (HGH) segment is estimated at % CAGR for the next seven-year period.
This treatment stimulates the immune system of patients to attack the foreign cells which cause the disease. Monoclonal antibodies are produced by using hybridoma technology. In hybridoma technology, the antibodies are obtained by fusion of human spleen cells and human myeloma. The characteristics of monoclonal antibodies which affect their efficacy are antigen specificity, overall structure and the affinity of the antibody for the target antigen or cells.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Monoclonal Antibodies, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Monoclonal Antibodies market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Monoclonal Antibodies market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Monoclonal Antibodies sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Monoclonal Antibodies covered in this report include Biocon, Celltrion, Dr. Reddy's Laboratories, Hospira, 3SBio, Accord Healthcare, AET Biotech, Allergan and Amega Biotech, etc.
The global Monoclonal Antibodies market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Biocon
Celltrion
Dr. Reddy's Laboratories
Hospira
3SBio
Accord Healthcare
AET Biotech
Allergan
Amega Biotech
Global Monoclonal Antibodies market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Monoclonal Antibodies market, Segment by Type:
Erythropoietin (EPO)
Human Growth Hormone (HGH)
Granulocyte- Colony Stimulating Factor (G-CSF)
Monoclonal Antibody (mAb)
Insulin
Interferon (IFN)
Others
Global Monoclonal Antibodies market, by Application
Anti-Cancer
Anti-Inflammatory/Autoimmune
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Monoclonal Antibodies manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Monoclonal Antibodies in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Monoclonal Antibodies Market Overview
1.1 Monoclonal Antibodies Product Overview
1.2 Monoclonal Antibodies Market Segment by Type
1.2.1 Erythropoietin (EPO)
1.2.2 Human Growth Hormone (HGH)
1.2.3 Granulocyte- Colony Stimulating Factor (G-CSF)
1.2.4 Monoclonal Antibody (mAb)
1.2.5 Insulin
1.2.6 Interferon (IFN)
1.2.7 Others
1.3 Global Monoclonal Antibodies Market Size by Type
1.3.1 Global Monoclonal Antibodies Market Size Overview by Type (2018-2029)
1.3.2 Global Monoclonal Antibodies Historic Market Size Review by Type (2018-2023)
1.3.3 Global Monoclonal Antibodies Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Monoclonal Antibodies Sales Breakdown by Type (2018-2023)
1.4.2 Europe Monoclonal Antibodies Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Monoclonal Antibodies Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Monoclonal Antibodies Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Monoclonal Antibodies Sales Breakdown by Type (2018-2023)
2 Global Monoclonal Antibodies Market Competition by Company
2.1 Global Top Players by Monoclonal Antibodies Sales (2018-2023)
2.2 Global Top Players by Monoclonal Antibodies Revenue (2018-2023)
2.3 Global Top Players by Monoclonal Antibodies Price (2018-2023)
2.4 Global Top Manufacturers Monoclonal Antibodies Manufacturing Base Distribution, Sales Area, Product Type
2.5 Monoclonal Antibodies Market Competitive Situation and Trends
2.5.1 Monoclonal Antibodies Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Monoclonal Antibodies Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Monoclonal Antibodies as of 2022)
2.7 Date of Key Manufacturers Enter into Monoclonal Antibodies Market
2.8 Key Manufacturers Monoclonal Antibodies Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Monoclonal Antibodies Status and Outlook by Region
3.1 Global Monoclonal Antibodies Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Monoclonal Antibodies Historic Market Size by Region
3.2.1 Global Monoclonal Antibodies Sales in Volume by Region (2018-2023)
3.2.2 Global Monoclonal Antibodies Sales in Value by Region (2018-2023)
3.2.3 Global Monoclonal Antibodies Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Monoclonal Antibodies Forecasted Market Size by Region
3.3.1 Global Monoclonal Antibodies Sales in Volume by Region (2024-2029)
3.3.2 Global Monoclonal Antibodies Sales in Value by Region (2024-2029)
3.3.3 Global Monoclonal Antibodies Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Monoclonal Antibodies by Application
4.1 Monoclonal Antibodies Market Segment by Application
4.1.1 Anti-Cancer
4.1.2 Anti-Inflammatory/Autoimmune
4.2 Global Monoclonal Antibodies Market Size by Application
4.2.1 Global Monoclonal Antibodies Market Size Overview by Application (2018-2029)
4.2.2 Global Monoclonal Antibodies Historic Market Size Review by Application (2018-2023)
4.2.3 Global Monoclonal Antibodies Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Monoclonal Antibodies Sales Breakdown by Application (2018-2023)
4.3.2 Europe Monoclonal Antibodies Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Monoclonal Antibodies Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Monoclonal Antibodies Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Monoclonal Antibodies Sales Breakdown by Application (2018-2023)
5 North America Monoclonal Antibodies by Country
5.1 North America Monoclonal Antibodies Historic Market Size by Country
5.1.1 North America Monoclonal Antibodies Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Monoclonal Antibodies Sales in Volume by Country (2018-2023)
5.1.3 North America Monoclonal Antibodies Sales in Value by Country (2018-2023)
5.2 North America Monoclonal Antibodies Forecasted Market Size by Country
5.2.1 North America Monoclonal Antibodies Sales in Volume by Country (2024-2029)
5.2.2 North America Monoclonal Antibodies Sales in Value by Country (2024-2029)
6 Europe Monoclonal Antibodies by Country
6.1 Europe Monoclonal Antibodies Historic Market Size by Country
6.1.1 Europe Monoclonal Antibodies Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Monoclonal Antibodies Sales in Volume by Country (2018-2023)
6.1.3 Europe Monoclonal Antibodies Sales in Value by Country (2018-2023)
6.2 Europe Monoclonal Antibodies Forecasted Market Size by Country
6.2.1 Europe Monoclonal Antibodies Sales in Volume by Country (2024-2029)
6.2.2 Europe Monoclonal Antibodies Sales in Value by Country (2024-2029)
7 Asia-Pacific Monoclonal Antibodies by Region
7.1 Asia-Pacific Monoclonal Antibodies Historic Market Size by Region
7.1.1 Asia-Pacific Monoclonal Antibodies Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Monoclonal Antibodies Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Monoclonal Antibodies Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Monoclonal Antibodies Forecasted Market Size by Region
7.2.1 Asia-Pacific Monoclonal Antibodies Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Monoclonal Antibodies Sales in Value by Region (2024-2029)
8 Latin America Monoclonal Antibodies by Country
8.1 Latin America Monoclonal Antibodies Historic Market Size by Country
8.1.1 Latin America Monoclonal Antibodies Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Monoclonal Antibodies Sales in Volume by Country (2018-2023)
8.1.3 Latin America Monoclonal Antibodies Sales in Value by Country (2018-2023)
8.2 Latin America Monoclonal Antibodies Forecasted Market Size by Country
8.2.1 Latin America Monoclonal Antibodies Sales in Volume by Country (2024-2029)
8.2.2 Latin America Monoclonal Antibodies Sales in Value by Country (2024-2029)
9 Middle East and Africa Monoclonal Antibodies by Country
9.1 Middle East and Africa Monoclonal Antibodies Historic Market Size by Country
9.1.1 Middle East and Africa Monoclonal Antibodies Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Monoclonal Antibodies Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Monoclonal Antibodies Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Monoclonal Antibodies Forecasted Market Size by Country
9.2.1 Middle East and Africa Monoclonal Antibodies Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Monoclonal Antibodies Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Biocon
10.1.1 Biocon Company Information
10.1.2 Biocon Introduction and Business Overview
10.1.3 Biocon Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Biocon Monoclonal Antibodies Products Offered
10.1.5 Biocon Recent Development
10.2 Celltrion
10.2.1 Celltrion Company Information
10.2.2 Celltrion Introduction and Business Overview
10.2.3 Celltrion Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Celltrion Monoclonal Antibodies Products Offered
10.2.5 Celltrion Recent Development
10.3 Dr. Reddy's Laboratories
10.3.1 Dr. Reddy's Laboratories Company Information
10.3.2 Dr. Reddy's Laboratories Introduction and Business Overview
10.3.3 Dr. Reddy's Laboratories Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Dr. Reddy's Laboratories Monoclonal Antibodies Products Offered
10.3.5 Dr. Reddy's Laboratories Recent Development
10.4 Hospira
10.4.1 Hospira Company Information
10.4.2 Hospira Introduction and Business Overview
10.4.3 Hospira Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Hospira Monoclonal Antibodies Products Offered
10.4.5 Hospira Recent Development
10.5 3SBio
10.5.1 3SBio Company Information
10.5.2 3SBio Introduction and Business Overview
10.5.3 3SBio Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2023)
10.5.4 3SBio Monoclonal Antibodies Products Offered
10.5.5 3SBio Recent Development
10.6 Accord Healthcare
10.6.1 Accord Healthcare Company Information
10.6.2 Accord Healthcare Introduction and Business Overview
10.6.3 Accord Healthcare Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Accord Healthcare Monoclonal Antibodies Products Offered
10.6.5 Accord Healthcare Recent Development
10.7 AET Biotech
10.7.1 AET Biotech Company Information
10.7.2 AET Biotech Introduction and Business Overview
10.7.3 AET Biotech Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2023)
10.7.4 AET Biotech Monoclonal Antibodies Products Offered
10.7.5 AET Biotech Recent Development
10.8 Allergan
10.8.1 Allergan Company Information
10.8.2 Allergan Introduction and Business Overview
10.8.3 Allergan Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Allergan Monoclonal Antibodies Products Offered
10.8.5 Allergan Recent Development
10.9 Amega Biotech
10.9.1 Amega Biotech Company Information
10.9.2 Amega Biotech Introduction and Business Overview
10.9.3 Amega Biotech Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Amega Biotech Monoclonal Antibodies Products Offered
10.9.5 Amega Biotech Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Monoclonal Antibodies Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Monoclonal Antibodies Industrial Chain Analysis
11.4 Monoclonal Antibodies Market Dynamics
11.4.1 Monoclonal Antibodies Industry Trends
11.4.2 Monoclonal Antibodies Market Drivers
11.4.3 Monoclonal Antibodies Market Challenges
11.4.4 Monoclonal Antibodies Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Monoclonal Antibodies Distributors
12.3 Monoclonal Antibodies Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
